{"filings":[{"id":2216719,"accession_number":"0001193125-26-346813","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-08-12T20:05:10+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Lumexa Imaging Q2 revenue up 5.1% to $264.2M; turns to net income of $2.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $264.2M, up 5.1% YoY from $251.4M; system-wide growth 6.0%.","Net income $2.7M vs net loss $7.2M; GAAP EPS $0.03, adjusted EPS $0.20.","Adjusted EBITDA $56.4M vs $56.3M; margin 21.4% vs 22.4%.","FY2026 guidance: revenue reaffirmed $1.045-1.097B; Adj EBITDA narrowed to $235-241M; Adj EPS $0.71-0.77.","Announced four new imaging centers YTD and JV with Hospital for Special Surgery (HSS)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1362716,"accession_number":"0001193125-26-290788","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-06-30T21:08:12+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Lumexa Imaging enters $823M term loan and $250M revolver amendment, maturing 2032/2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Secured term loan of ~$823M at SOFR+2.50% or Prime+1.50%, matures December 2032.","Secured revolving facility of $250M at same rates, matures December 2030.","Proceeds used to repay existing Amendment No. 5 term loans and pay fees/expenses.","Financial covenant: net leverage ≤7.50x if revolving usage exceeds 40% of facility.","Interest rate on revolving loans reduced via amendment; quarterly amortization of 0.25% of term loan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1027237,"accession_number":"0001193125-26-269379","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-06-12T20:05:13+00:00","items":["5.07","9.01"],"status":"ready","headline":"Lumexa Imaging elects Class I directors and ratifies PwC as auditor at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Lee Cooper, Brian Regan, and Caitlin Zulla as Class I directors; each to serve until 2029.","Lee Cooper: 87,523,628 votes for, 3,328,050 withheld, 826,898 broker non-votes.","Brian Regan: 80,044,532 votes for, 10,807,146 withheld, 826,898 broker non-votes.","Caitlin Zulla: 87,156,663 votes for, 3,695,015 withheld, 826,898 broker non-votes.","Ratified PricewaterhouseCoopers as independent auditor for fiscal 2026: 91,555,829 for, 66,858 against, 55,889 abstentions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":40363,"accession_number":"0001193125-26-219415","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-05-12T20:08:46+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Lumexa Q1 rev $252.5M (+3.1%); net income $1.7M vs loss; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated revenues of $252.5M, up 3.1% YoY; net income $1.7M vs net loss of $7.7M.","GAAP EPS $0.02; Adjusted EPS $0.18; Adjusted EBITDA $51.2M (20.3% margin) vs $51.0M.","Same-center advanced volume growth of 5.6% for both consolidated and system-wide.","Announced four new centers: two tuck-in acquisitions and two de novos; on track for 8-10 de novos in 2026.","FY 2026 guidance reaffirmed: rev $1.045-1.097B, Adj EBITDA $234-242M, Adj EPS $0.71-0.77."],"consensus_eps_estimate":0.1239,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":252537000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97572,"accession_number":"0001193125-26-149837","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Lumexa reiterates FY2026 guidance at investor meeting","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Held meeting and site visit on April 8, 2026; reaffirmed previously disclosed full year 2026 guidance.","No new financial projections or adjusted guidance were provided in the update.","Guidance figures remain unchanged from prior disclosure; no specific numbers cited in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112486,"accession_number":"0001193125-26-124978","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Lumexa Q4 rev $267.7M (+7.9%), Adj EBITDA $63.8M (+18.6%); reiterates 2026 guide","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 consolidated revenues $267.7M (+7.9% YoY); net loss $28.7M vs $25.1M loss in Q4 2024.","Q4 adjusted EBITDA $63.8M (+18.6% YoY), margin 23.8%; consolidated same-center advanced volume growth 12.7%.","Full year 2025 revenues $1.023B (+7.8% YoY); net loss $47.1M vs $94.1M loss; adjusted EBITDA $230.2M (+14.6%).","Leverage reduced from 5.5x to 3.5x, generating over $50M in annual cash savings.","2026 guidance reaffirmed: revenues $1.045B-$1.097B, adjusted EBITDA $234M-$242M, adjusted EPS $0.71-$0.77."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112485,"accession_number":"0001193125-26-084047","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Lumexa Imaging prelim Q4 rev at least $261M, FY rev at least $1.016B; guides FY 2026 rev $1.045-1.097B","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Prelim Q4 2025 rev at least $261M (+5.2% YoY); adj. EBITDA at least $63M (+17% YoY).","Prelim FY 2025 rev at least $1.016B (+7.1% YoY); adj. EBITDA at least $229M (+14% YoY).","FY 2026 guidance: rev $1.045-1.097B, adj. EBITDA $234-242M (incl. ~$7M public co. costs).","Net loss improved: FY 2025 prelim loss not larger than $43.8M vs $94.1M prior year.","Opened 9 de novo centers in 2025; PET volumes up 17% consolidated; AI pilot in NJ."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112484,"accession_number":"0001193125-26-013511","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2026-01-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Lumexa Imaging Chief Legal Officer Julie Szeker resigns effective March 13, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation not due to any disagreement with the company on operations, policies, or practices.","Transition payment of $450,000 (12 months base salary) plus up to 12 months of subsidized COBRA coverage.","Will receive $250,000 annual bonus for 2025 performance, paid when other employees receive bonuses.","Company has initiated a process to identify a successor; Szeker to stay through March 13 for transition.","Transition agreement includes a release of claims and non-disparagement obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129051,"accession_number":"0001193125-25-324774","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Lumexa refinances $825M term loan and $250M revolver; maturities extended to 2032 and 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$825M secured term loan facility (Refinancing Term Loan) priced at SOFR+3% or Prime+2%, maturing December 2032.","$250M secured revolving credit facility (Amended Revolving Credit Facility) at same rates with step-down pricing, maturing December 2030.","Financial covenant requires net leverage ≤7.50x if revolving exposure exceeds 40% of the $250M facility at quarter end.","Proceeds used to repay existing Amendment No. 3 term loans and pay related fees and expenses.","Barclays Bank PLC acts as administrative agent, issuing bank and swing line lender; guarantees from all material subsidiaries remain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129050,"accession_number":"0001193125-25-317521","cik":2071288,"company_name":"Lumexa Imaging Holdings, Inc.","ticker":"LMRI","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["1.01","5.02","5.03","8.01","9.01"],"status":"ready","headline":"Lumexa Imaging closes IPO of 25M shares at $18.50, raises ~$462.5M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 25,000,000 shares priced at $18.50 per share closed on Dec 12, 2025.","Net proceeds to repay Barclays secured term loan and for working capital and capex.","Four new directors appointed: Brett Brodnax, Bridget Karlin, Matthew Lungren, Robert Mittl.","Stockholders agreement with Welsh Carson grants board nomination rights at ownership thresholds.","Post-IPO charter and bylaws became effective; indemnification agreements with directors/officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":734056789.4715027,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}